ProfileGDS5678 / 1430244_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 61% 59% 58% 57% 57% 62% 60% 58% 57% 59% 59% 58% 59% 59% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.6747861
GSM967853U87-EV human glioblastoma xenograft - Control 23.5206159
GSM967854U87-EV human glioblastoma xenograft - Control 33.4929458
GSM967855U87-EV human glioblastoma xenograft - Control 43.4058957
GSM967856U87-EV human glioblastoma xenograft - Control 53.4304157
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.8088962
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.6643660
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.5044958
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.4577257
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.5165659
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.5236759
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.4408258
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.5591959
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.5227559